Published in Antimicrob Agents Chemother on January 01, 1995
Filamentous Bacteriophage Promote Biofilm Assembly and Function. Cell Host Microbe (2015) 1.46
Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2013) 1.17
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J Antimicrob Chemother (2009) 1.12
Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10
P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob Agents Chemother (2001) 1.08
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol (2010) 1.01
Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection. Am J Respir Crit Care Med (2011) 0.97
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis. Antimicrob Agents Chemother (2009) 0.96
Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2012) 0.92
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. BMC Microbiol (2012) 0.92
In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother (2008) 0.90
Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin. J Aerosol Med Pulm Drug Deliv (2012) 0.88
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Adv Drug Deliv Rev (2014) 0.87
Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. Antimicrob Agents Chemother (2014) 0.84
Differential protection from tobramycin by extracellular polymeric substances from Acinetobacter baumannii and Staphylococcus aureus biofilms. Antimicrob Agents Chemother (2014) 0.84
Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis. Clin Med Insights Circ Respir Pulm Med (2013) 0.81
Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis. PLoS One (2009) 0.79
Mucin Binding Reduces Colistin Antimicrobial Activity. Antimicrob Agents Chemother (2015) 0.78
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection. Antimicrob Agents Chemother (2012) 0.78
Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2015) 0.77
Real-world challenges to the practice of evidence-based medicine. Can J Hosp Pharm (2012) 0.75
Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin. BMC Microbiol (2015) 0.75
Bacterial Biofilm Control by Perturbation of Bacterial Signaling Processes. Int J Mol Sci (2017) 0.75
Mutants of Escherichia coli requiring methionine or vitamin B12. J Bacteriol (1950) 88.88
The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem (1958) 11.74
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
In vitro studies of tobramycin, an aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 3.23
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A (1990) 2.99
Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics (1959) 2.65
Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother (1980) 2.01
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas. Antimicrob Agents Chemother (1972) 1.67
Interaction of purulent material with antibiotics used to treat Pseudomonas infections. Antimicrob Agents Chemother (1974) 1.41
Endobronchial pH. Relevance of aminoglycoside activity in gram-negative bacillary pneumonia. Am Rev Respir Dis (1983) 1.33
Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa. J Infect Dis (1976) 1.22
Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum. J Infect Dis (1983) 1.21
Pus, deoxyribonucleic acid, and sputum viscosity. Thorax (1978) 1.20
Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis (1980) 1.13
Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions. Pediatrics (1965) 1.09
The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum. J Antimicrob Chemother (1988) 1.06
Relative antagonism in vitro of calcium in serum to the bactericidal activities of gentamicin and tobramycin on Pseudomonas aeruginosa. Chemotherapy (1973) 1.02
Inflammatory reaction and airway damage in cystic fibrosis. J Lab Clin Med (1976) 1.02
The differential attachment of antibiotics to glycoprotein and blood lymphocytes. J Clin Pathol (1970) 0.90
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98
Cooperation within actin filament in vertebrate skeletal muscle. Nat New Biol (1972) 7.00
Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23
The relationship between caffeine contracture of intact muscle and the effect of caffeine on reticulum. J Gen Physiol (1968) 5.86
Maturation of the immune response in germinal centers. Cell (1991) 5.68
Why doesn't audit work? BMJ (1998) 5.63
Molecular control mechanisms in muscle contraction. Physiol Rev (1973) 5.48
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12
Private company wins rights to Icelandic gene database. BMJ (1999) 4.04
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03
Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci (1970) 3.29
[Chlorophylls and carotenoids of the chaetophorineae (Chlorophyceae, Ulotricholes). 1. Siphonax-anthin in microthamnion kuetzingianum naegeli]. Arch Mikrobiol (1972) 3.10
On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun (1968) 3.10
[The path to "Doctor of Medicine"--how do doctoral candidates evaluate their dissertation?]. Dtsch Med Wochenschr (1998) 2.95
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Gender gap in cystic fibrosis mortality. Am J Epidemiol (1997) 2.74
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol (1999) 2.73
Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet (2003) 2.72
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71
The Arabidopsis sex1 mutant is defective in the R1 protein, a general regulator of starch degradation in plants, and not in the chloroplast hexose transporter. Plant Cell (2001) 2.63
The mechanism of the action of caffeine on sarcoplasmic reticulum. J Gen Physiol (1968) 2.56
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
Silicon nanowire-based solar cells on glass: synthesis, optical properties, and cell parameters. Nano Lett (2009) 2.41
Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36
The randomized shortened dental arch study: tooth loss. J Dent Res (2010) 2.35
Expression of CD68 in non-myeloid cell types. Scand J Immunol (2008) 2.32
Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30
Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol (2000) 2.29
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28
Adrenocorticotropin insensitivity syndromes. Endocr Rev (1998) 2.27
How Listeria exploits host cell actin to form its own cytoskeleton. II. Nucleation, actin filament polarity, filament assembly, and evidence for a pointed end capper. J Cell Biol (1992) 2.26
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Studies in the epidemiology and control of seasonal conjunctivitis and trachoma in southern Morocco. Bull World Health Organ (1968) 2.07
Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07
Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child (1977) 2.04
Retracted Acute normovolaemic haemodilution vs controlled hypotension for reducing the use of allogeneic blood in patients undergoing radical prostatectomy. Br J Anaesth (1999) 2.03
Isolation and assay of rabies serogroup viruses in CER cells. Intervirology (1977) 2.03
Conformational studies of poly-L-alanine in water. Biopolymers (1968) 2.02
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00
Position-dependent accommodative shift of retropupillary fixated iris-claw lenses. Graefes Arch Clin Exp Ophthalmol (2012) 2.00
Antibiotics and invasive Haemophilus influenzae. N Engl J Med (1976) 2.00
Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Sepsis and congenital asplenia. J Pediatr (1977) 1.93
T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92
In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84
Clinical staging in Reye syndrome. Am J Dis Child (1974) 1.84
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr (2001) 1.83
An actin monomer binding activity localizes to the carboxyl-terminal half of the Saccharomyces cerevisiae cyclase-associated protein. J Biol Chem (1995) 1.83
The interfascicular nerve-grafting of the median and ulnar nerves. J Bone Joint Surg Am (1972) 1.82
Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol (1989) 1.82
Molecular characterization of a carbon transporter in plastids from heterotrophic tissues: the glucose 6-phosphate/phosphate antiporter. Plant Cell (1998) 1.82
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology (1978) 1.81
Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics (1998) 1.80
Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis (1999) 1.79
'Microsmatic' primates revisited: olfactory sensitivity in the squirrel monkey. Chem Senses (2000) 1.79
Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79
Pilonidal sinus disease. J Visc Surg (2013) 1.76
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet (2009) 1.74
Riboflavin and mouse hepatic cell structure and function. II. Division of mitochondria during recovery from simple deficiency. J Cell Biol (1969) 1.74
A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73
A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res (1997) 1.73
Parallel response of myofibrillar contraction and relaxation to four different nucleoside triphophates. J Gen Physiol (1969) 1.70
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Regulatory mechanisms of the calcium transport system of fragmented rabbit sarcoplasmic rticulum. I. The effect of accumulated calcium on transport and adenosine triphosphate hydrolysis. J Gen Physiol (1971) 1.69
Continuous elemental enteral alimentation in children with Crohn's disease and growth failure. Gastroenterology (1980) 1.68
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67
Persistence of pedicle blood flow up to 10 years after free musculocutaneous tissue transfer. Plast Reconstr Surg (1998) 1.67
An actin-nucleating activity in polymorphonuclear leukocytes is modulated by chemotactic peptides. J Cell Biol (1986) 1.67
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci (1985) 1.67
A new class of plastidic phosphate translocators: a putative link between primary and secondary metabolism by the phosphoenolpyruvate/phosphate antiporter. Plant Cell (1997) 1.66
Comparative virulence of Haemophilus influenzae with a type b or type d capsule. Infect Immun (1981) 1.66
Requirement of pointed-end capping by tropomodulin to maintain actin filament length in embryonic chick cardiac myocytes. Nature (1995) 1.66
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Effects of a bronchoprovocation challenge test with cigarette sidestream smoke on sensitive and healthy adults. Chest (1993) 1.65
Increasing incidence of ampicillin resistance in Hemophilus influenzae. J Pediatr (1978) 1.63
On estimating recessive frequencies from truncated samples. Biometrics (1967) 1.62
Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.60